The toxicities of a variety of metals and metalloids have been formally assayed in
C elegans and include Ag, Al, Ar, Cd, Co, Cr, Cu, Hg, Pb, Ti, Ur, and Zn (
Bruinsma et al., 2008;
Calafato et al., 2008;
Dhawan et al., 2000;
Guo et al., 2009;
Jiang et al., 2009;
Liao and Yu, 2005;
Ma et al., 2009;
Roh et al., 2009;
Wang et al., 2007,
2009;
Ye et al., 2008). However, studies on the toxicity of selenium have not been previously reported. Through the results presented here we demonstrate that selenium in the form of Na
2SeO
3 both prevents and induces oxidative stress in
C elegans through a process that involves the GLRX-21 glutaredoxin.
Removal of hydrogen peroxide from cells occurs through the activities of one of three enzymes, glutathione peroxidase, catalase, or peroxiredoxins (
Nordberg and Arnér, 2001) but has also been shown to be reduced by a thioredoxin reductase–dependent pathway (
Björnstedt et al., 1995). TRXR-1, an ortholog of the human enzymatic antioxidant thioredoxin reductase-1 has been demonstrated to be the only selenoprotein in
C elegans (
Gladyshev et al., 1999;
Taskov et al., 2005). Our observation that at the midrange concentrations (1–2mM) selenium is protective against H
2O
2-induced toxicity, whereas at the lowest ranges (0.001–0.01mM) selenium is toxic () suggests that in
C elegans selenium incorporation into enzymatic antioxidant selenoproteins may be dosage dependent. In previous studies examining the effects of dietary selenium levels on the activity of glutathione peroxidase and thioredoxin reductase, the activity of both enzymes was shown to gradually increase as the concentration of selenium in the feed increased (
Hadley and Sunde, 2001;
Sunde and Hadley, 2010). Yet, in both cases, selenoprotein activity reached a plateau after which increasing selenium concentration did not increase the activity of the enzymes. In our studies, as selenium concentration neared the Se-LC
50 (3.47mM), it ceased to have any measurable antioxidant effect, and increasing lethality was observed within the population as exposure levels increased (). With increasing Na
2SeO
3 concentration, hydrogen selenide (H
2Se) produced by the excess selenium would generate ROS causing oxidative stress rather than becoming incorporated into antioxidant selenoproteins (
Letavayová, et al., 2006). Our findings of elevated ROS levels in animals exposed to excess selenium () lend support to this theory. Additionally, selenium-dependent oxidation of GSH would in turn further sensitize cells to hydrogen selenide–induced superoxide anions leading to even greater oxidative stress. The dose-dependent ability of glutathione to suppress the ROS formation (), lethality (), and motility impairment () induced by excess selenium is consistent with the predicted depletion of GSH levels by the thiol oxidizing properties of hydrogen selenide and suggests that decreased GSH levels play a key role in the cytotoxic effects of selenium. This is consistent with a recent finding showing that GSH depletion in cells led to the increased sensitivity of cells to selenite (
Wallenberg et al., 2010).
The glutaredoxin proteins (GLRXs) are not selenoproteins and thus are not directly affected or regulated by the levels of selenium in cells, but function in the reduction of proteins and low–molecular weight mixed disulfides. Under conditions of oxidative stress, the glutaredoxins can reverse this role and instead catalyze the formation of mixed disulfides, thus preventing further oxidation of thiols such as GSH (
Fernandes and Holmgren, 2004;
Holmgren, 2000;
Lillig et al., 2008). During selenium-induced oxidative stress, the glutaredoxins have been demonstrated to be an essential component in the cellular response of yeast and cyanobacteria (
Lewinska and Bartosz, 2008;
Marteyn et al., 2009). The acceleration of the timing of motility impairment observed with the loss of the
C elegans GLRX-21 protein ( and
Supplementary fig. 2B) is consistent with a role for glutaredoxin in the cellular responses of
C elegans to selenium-induced oxidative stress. In addition, our finding that the loss of functional GLRX-21 protein in worms reversed the suppressive effects of GSH on lethality (), suggests that GLRX-21 is required for this GSH function. GLRX-21 is an ortholog of the human GLRX2 protein (;
Sagemark et al., 2007), which has been shown to reduce mitochondrial apoptotic cell death induced by ROS-producing agents (
Holmgren, et al., 2005;
Lundberg et al., 2001). Like all GLRX proteins, GLRX2 is maintained in its reduced active form by GSH, which binds to specific sites within the GLRX2 protein that are highly conserved across glutaredoxins (). The data presented here suggest similarly that activation of GLRX-21 by GSH may be required for the reduced lethality observed with increasing GSH concentration in our selenium-treated animals ().
The lethality rate and the LC
50 value obtained from our liquid assays provided a useful general measure of the relative toxicity of selenium compared with other metals previously assayed in this model. Yet, as demonstrated in , a 5mM Na
2SeO
3 exposure of animals on agar plates caused death in only 22.5 (±12.14)% of the animals after 24-h exposure versus 79.2 (±18.01)% of the animals exposed to 5mM Na
2SeO
3 in our liquid assay with only a 12-h exposure period (). This reduction in lethality of animals exposed on agar media allowed the additional observation of a selenium-induced motility phenotype that occurred prior to death (). Locomotion in
C elegans requires the coordination of three main groups of neurons: sensory neurons, interneurons, and the motor neurons that innervate the body wall muscles (
Whittaker and Sternberg 2004). If selenium exposure causes progressive damage to the energy-producing functions of the muscles and/or neurons controlling movement, the resultant reduced energy availability could potentially lead to the observed gradual slowing of movement over time. Yet, our later observations showed that the motility phenotype could be further broken down into two distinct movement defects: impaired backing in response to head tap and paralysis (). In our studies examining single animals chronically exposed to selenium (), the observation that these phenotypes occurred progressively from a period of impaired backing before paralysis and paralysis before dying suggests that there is a stereotypic sequence of cellular damage caused by selenium. Because the ability to coordinate backward movement occurs prior to the more generalized paralysis phenotype, the cells involved in backward movement would appear to be more sensitive to selenium-induced toxicity, whereas those required for forward movement would seem less sensitive. Our observation that a subset of animals that had impaired backing were able to resume normal movement after removal from selenium (), suggests that the damage that had been done to those cells was reversible. Thus, the progression of phenotypes could represent the induction of a multistep pathway leading to cellular dysfunction and cell death that could become irreversible by the time enough damage has accumulated. This hypothesis was supported by the fact that paralyzed animals did not recover ().
In conclusion, our findings suggest
C elegans as an excellent model for elucidating the mechanisms of selenium toxicity. The identification of roles for both glutathione and glutaredoxins in the cellular responses to selenium suggests that many of the processes involved in the selenium-induced toxicity observed in
C elegans are similar to those observed within the context of other systems (
Izquierdo et al., 2010;
Lewinska and Bartosz, 2008;
Wallenberg et al., 2010). As a model organism,
C elegans has many features that make it an advantageous system for continued analysis on the effects of genes and pharmacological treatments on selenium-induced toxicity including: a short generation time, small nervous system (302 neurons), and conserved cellular signaling pathways (
Riddle et al., 1997). These distinctive advantages of
C elegans have proved very useful to investigations examining the impact of environmental toxicants (
Leung et al., 2008;
Peterson et al., 2008) and to models of medically relevant disease processes as diverse as Huntington’s disease, Parkinson’s disease, Alzheimer’s disease, apoptosis, and stroke (
Faber et al., 2002;
Horvitz et al., 1994;
Levitan and Greenwald, 1998;
Nass et al., 2008;
Scott et al., 2002;
Westlund et al., 1999). The movement assay described herein should provide a sensitive tool for further genetic and molecular analysis of selenium-induced toxicity.